Furthermore, FGF16 promotes angiogenesis in breast cancer by simultaneously enhancing hypoxia-inducible transcription factor 1α (HIF1α) and activator protein-1 (AP-1) mediated vascular endothelial growth factor A (VEGF-A) transcription [20]. Here, HIF1A is linked to breast carcinoma.